Squair, Daniel R.
Virdee, Satpal http://orcid.org/0000-0002-7052-9802
Funding for this research was provided by:
RCUK | Medical Research Council (MC_UU_12016/8, MC_UU_12016/8)
RCUK | Biotechnology and Biological Sciences Research Council (BB/ P003982/1)
Article History
Received: 23 February 2022
Accepted: 21 June 2022
First Online: 27 July 2022
Competing interests
: S.V. is a founder and shareholder of Outrun Therapeutics, a biotech company investigating the ubiquitin system. D.R.S. declares no competing interests.